Mineralys Therapeutics, Inc.
MLYS
Revenue
0.00
0.000.00%
-Assets
318.49M
▼-28.76M▼-8.28%
3 Months ChangeLiabilities
28.40M
▲9.19M▲47.87%
3 Months ChangeFree Cash Flow
-19.20M
▼-6.42M▼-50.28%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001933414-24-000050
2024-09-25
Form 8-K
ID: 0001933414-24-000044
2024-08-13
Form 10-Q
ID: 0001933414-24-000039
2024-08-13
Form 8-K
ID: 0001933414-24-000038
2024-06-14
Form 8-K
ID: 0001933414-24-000028
2024-06-10
Form 8-K
ID: 0001933414-24-000025
2024-05-31
Form 8-K
ID: 0001933414-24-000024
2024-05-22
Form 8-K
ID: 0001933414-24-000017
2024-05-09
Form 10-Q
ID: 0001933414-24-000016
2024-05-09
Form 8-K
ID: 0001933414-24-000015